A novel validated method for predicting the risk of re-hospitalization for worsening heart failure and the effectiveness of the diuretic upgrading therapy with tolvaptan.
Increased re-hospitalization due to acute decompensated heart failure (ADHF) is a modern issue in cardiology. The aim of this study was to investigate risk factors for re-hospitalization due to worsening heart failure, and the effect of tolvaptan (TLV) on decreasing the number of re-hospitalizations...
Main Authors: | Hideyuki Takimura, Tasuku Hada, Mami Kawano, Takayuki Yabe, Yukako Takimura, Satoru Nishio, Masatsugu Nakano, Reiko Tsukahara, Toshiya Muramatsu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6235362?pdf=render |
Similar Items
-
Tolvaptan: A Novel Diuretic in Heart Failure Management
by: Hilman Zulkifli Amin, et al.
Published: (2016-07-01) -
Congestion and Diuretic Resistance in Acute or Worsening Heart Failure
by: Ingibjörg Kristjánsdóttir, et al.
Published: (2020-09-01) -
Total body fluid is the factor that affects the pharmacokinetics of tolvaptan, and its efficacy, in acute worsening heart failure patients
by: Takahiro Kato, et al.
Published: (2023-06-01) -
Use of tolvaptan in patients hospitalized for worsening chronic heart failure with severe hyponatremia: The initial experience at a single-center in Turkey
by: Saim Sağ, et al.
Published: (2017-07-01) -
Outpatient treatment of worsening heart failure with intravenous diuretics: first results from a multicentre 2‐year experience
by: Eric Wierda, et al.
Published: (2023-02-01)